Comparison of three different purification methods for the routine preparation of [11C] metomidate

Applied Radiation and Isotopes

Volumn 59, Issue 2-3, 2003, Pages 125-128

  Mitterhauser, Markus ^a,b   Wadsak, Wolfgang ^a,c   Langer, Oliver ^a   Schmaljohann, Joern ^d   Zettinig, Georg ^a,c   Dudczak, Robert ^a,c   Viernstein, Helmut ^a   Kletter, Kurt ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^d UNIVERSITY OF BONN   (Germany)

Author keywords

11 hydroxylase; Preparation; Purification; 11C Metomidate; 18F FETO

Indexed keywords

POLYETHYLENE TEREPHTHALATES; PURIFICATION; SOLVENTS;

ACIDIC SOLVENTS;

CARBON;

ACID; CARBON 11; METHYL IODIDE; METHYL IODIDE C 11; METOMIDATE C 11; SOLVENT; UNCLASSIFIED DRUG;

ADRENAL CORTEX TUMOR; ARTICLE; COMPARATIVE STUDY; FEASIBILITY STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PURIFICATION; REACTION ANALYSIS; TECHNIQUE;

EID: 0042521233     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8043(03)00168-4     Document Type: Article

References (9)

1. 11C] metomidate as potential tracers for pet imaging of the adrenal cortex and its tumors. J Nucl Med. 39:1998;982-989.
2. 11C] metomidate. J Nucl Med. 41(2):2000;275-282.
3. Damani L.A., Mitterhauser M., Zolle I., Lin G., Oehler E., Ho Y.P. Metabolic and pharmacokinetic considerations in the design of 2-phenyl substituted metyrapone derivatives. 2-methoxyphenylmetyrapone as a radioligand for functional diagnosis of adrenal pathology Nucl Med Biol. 22(8):1995;1067-1074.
4. 11C] metomidate and pet. Eur. J Nucl Med [Suppl. 1]. 29:2002;S117. (abstract).
5. 18F] FDG for PET imaging of metastases from adrenocortical origin. Eur. J Nucl Med. 29(Suppl. 1):2002;S372. (abstract).
6. 11C] metomidate for PET. Eur. J Nucl Med. 29(Suppl. 1):2002;S6. (abstract).
7. Schwaiger M. Highlights of the 15th annual congress of the European Association of Nuclear Medicine, Vienna. Eur. J Nucl Med. 30:2003;165-6180.
8. Suzuki H., Shibata H., Maruyama T., Ishimura Y., Saruta T. Significance of steroidogenic enzymes in the pathogenesis of hyperfunctioning and non-hyperfunctioning adrenal tumor. Steroids. 60:1995;42-47.
9. 18F] FETO, a novel potential 11β-hydroxylase inhibitor. J Labelled Compd Radpharm. 46:2003;379-388.